Urgent.News

What's breaking now, across hundreds of outlets.

Finance & Markets

Filana Therapeutics CFO Eric Schoen buys $8,400 in shares

Filana Therapeutics CFO Eric Schoen buys $8,400 in shares

On November 16, 2026, Filana Therapeutics' CFO Eric Schoen purchased 20,000 shares of the company's common stock, investing $8,400. The transaction occurred as the stock traded below its current price of $0.64, experiencing a surge of over 50% in the preceding week. InvestingPro analysis suggests that Fluana Therapeutics Inc. (FLNA) may be undervalued, despite carrying more cash than debt while rapidly depleting cash reserves.

Following this acquisition, Mr. Schoen now directly owns 31,500 shares of FILANA THERAPEUTICS common stock.

Simultaneously, Filana Therapeutics, Inc. faced a legal challenge in a securities class action. The Fifth Circuit Court of Appeals overturned a prior ruling by the U.S. District Court for the Western District of Texas, which had granted class certification. The appellate court determined that the District Court incorrectly applied the legal standard for class certification.

Additionally, Filana Therapeutics argued that the meme-stock phenomena impacted the company's securities during the proposed class period. These legal proceedings are an ongoing aspect of the company's operations.

Rewritten by urgent.news; may contain errors — check the original.

Read the original at investing.com →

Report a problem with this story

More in Finance & Markets

More from Sunday 22 November →